Seres Therapeutics MCRB

$ 0.92 10.44%

Quarterly report 2024-Q2
added 08-13-2024

Seres Therapeutics EV/EBITDA Ratio 2011-2024 | MCRB

Annual EV/EBITDA Ratio Seres Therapeutics

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-13.3	-23.2	-2.37	-1.77	-4.58	-3.62	-10.3	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-1.77	-23.2	-8.45